• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Alcon launches the Clareon Family of IOLs in India


The Clareon platform will be available in India in 2 Presbyopia correcting IOL technologies: the Clareon PanOptix and Clareon Vivity.

(Image Credit: AdobeStock/David Costa Art)

(Image Credit: AdobeStock/David Costa Art)

Alcon has launched the Clareon Family of intraocular lenses (IOLs) in India, which features Alcon’s “most advanced IOL material in its 20+ years of IOL innovation.”1

Announced in a press release from the company,1 it is also stated that the Clareon platform will be available in India in 2 Presbyopia correcting IOL technologies: the Clareon PanOptix and Clareon Vivity.

The Clareon PanOptix Trifocal IOL offers spectacle independence across all distances and has been implanted over 2.2 million times globally, making it the most implanted trifocal IOL globally, according to Alcon.1 It offers patients the possibility of 20/20 vision at distance (far), intermediate (at arm’s length) and near (up close), with continuous vision of 20/25 or better.

While the Clareon Vivity IOL is designed to extend vision with wavefront-shaping X-WAVE™ technology, and simplify the presbyopia-correcting experience for surgeons and patients while delivering monofocal- like certainty.

“We are proud to offer the full range of our latest IOL technology to patients in India. At Alcon, we are consistently pushing the boundaries to deliver transformational innovation to cataract surgeons and their patients,” said Amar Vyas, Country Head of Alcon India. “Clareon builds on Alcon’s long legacy of IOL innovation and is the result of robust R&D efforts at every level—inventive material science, advanced manufacturing techniques and novel delivery systems. Our most advanced platform to date, Clareon delivers exceptional, long-lasting clarity.”

Clareon IOLs are inserted using the next-generation, reusable Clareon Monarch® IV Delivery System and according to the company, the Clareon portfolio leverages many of the same design characteristics and optics as Alcon’s leading IOLs to help deliver the outcomes surgeons expect.1

  1. Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India. Press release; March 12, 2024. Accessed March 12, 2024. https://www.businesswire.com/news/home/20240311739700/en/
Related Videos
William F. Wiley, MD, shares some key takeaways from his ASCRS presentation on binocularity and aperture optics.
© 2024 MJH Life Sciences

All rights reserved.